This FDA funding opportunity supports research to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro-in vivo correlations (IVIVCs) for long-acting injectable suspensions and implants. The grant is a U01 cooperative agreement with an optional clinical trial component, aiming to advance drug development and regulatory science in this area.
Eligibility details are not specified in the grant listing. Contact the Food and Drug Administration for requirements.
